drugset / Trial / NCT02702700

Photo-induction as a Means to Improve Cisplatin Delivery to Pleural Malignancies

NCT02702700

Phase 1 Terminated 1 enrolled Centre Hospitalier Universitaire Vaudois
NaSingle-groupOpen-labelTreatment

Summary

This clinical study aims to explore intrapleural low-dose Visudyne®-mediated photodynamic therapy (photo-induction) as a pathway to promote the uptake of systemically administered Lipoplatin™ in pleural malignancies of patients undergoing video-assisted talcage for their malignant pleural effusions. Photo-induction is expected to overcome the chemo-resistance of pleural malignancies for cisplatin-based chemotherapeutics and thereby improve local tumor control.

Timeline

Start
2016-01
Primary completion
2018-08-28
Completion
2018-08-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 200 mg/m2 Intravenous
Subject Verteporfin Other / unclassified 3 mg/m2 Intravenous

Indications